Table 4 Lymph node staging and initial and final tumor staging in the subgroup of patients reestablished after identification of lymph node micrometastases by IHC and MS techniques in gastric carcinoma (n = 15).

From: Impact of multisection and immunohistochemistry in lymph node staging of Gastric Carcinoma – Case series

Patient #

Lymph node staging before MS/IHC

Tumoral staging before MS/IHC

Lymph node staging after MS/IHC

Tumoral staging after MS/IHC

2

N3a

IIIA

N3b*

IIIB**

4

N3a

IIIB

N3b*

IIIC**

11

N1

IIB

N2*

IIIA**

16

N1

IIB

N2*

IIIA**

18

N1

IIIA

N2*

IIIA

20

N1

IIIA

N2*

IIIA

25

N1

IIIA

N2*

IIIA

29

N0

IA

N1*

IB**

34

N1

IIA

N2*

IIB**

35

N0

IB

N1*

IIA**

36

N1

IIA

N2*

IIB**

39

N0

IIB

N1*

IIIA**

41

N2

IIIA

N3b*

IIIC**

45

N0

IIB

N2*

IIIA**

50

N0

IIA

N1*

IIB**

  1. *Cases where there was a change in the category of lymph node staging, **Cases in which tumor staging was changed, MS - lymph node multisection, IHC – immunohistochemistry.
Back to article page